摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-2-hydroxy-3-(3-aminophenyl)propanoic acid | 921195-80-4

中文名称
——
中文别名
——
英文名称
(+/-)-2-hydroxy-3-(3-aminophenyl)propanoic acid
英文别名
(±)-2-hydroxy-3-(3'-aminophenyl)propionic acid;3-(3-aminophenyl)-2-hydroxypropanoic acid
(+/-)-2-hydroxy-3-(3-aminophenyl)propanoic acid化学式
CAS
921195-80-4
化学式
C9H11NO3
mdl
——
分子量
181.191
InChiKey
GRTDDRVEWZAQCG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    416.8±30.0 °C(Predicted)
  • 密度:
    1.356±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    83.6
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-hydroxy-3-(3-nitrophenyl)propionic acid 在 5%-palladium/activated carbon 氢气 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以100%的产率得到(+/-)-2-hydroxy-3-(3-aminophenyl)propanoic acid
    参考文献:
    名称:
    Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field
    摘要:
    本发明涉及具有一般式(I)的化合物,其中R1和R2,可以相同也可以不同,选自包括-H或具有1至6个碳原子的直链或支链烷基基团,或者共同形成具有5或6个原子的芳香或脂肪环的群;Y和Z,可以相同也可以不同,选自包括-H,-OH,-COOH,-OR3,-CH(OR3)COOH的群,其中R3选自H,苯基,苄基,-CF3或-CF2CF3,乙烯基,烯丙基和具有1至6个碳原子的直链或支链烷基基团。
    公开号:
    US20090048343A1
点击查看最新优质反应信息

文献信息

  • Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field
    申请人:Naccari Giancarlo
    公开号:US20090048343A1
    公开(公告)日:2009-02-19
    The present invention relates to compounds comprising the general formula (I), in which R 1 and R 2 , which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
    本发明涉及具有一般式(I)的化合物,其中R1和R2,可以相同也可以不同,选自包括-H或具有1至6个碳原子的直链或支链烷基基团,或者共同形成具有5或6个原子的芳香或脂肪环的群;Y和Z,可以相同也可以不同,选自包括-H,-OH,-COOH,-OR3,-CH(OR3)COOH的群,其中R3选自H,苯基,苄基,-CF3或-CF2CF3,乙烯基,烯丙基和具有1至6个碳原子的直链或支链烷基基团。
  • [EN] METHODS OF TREATING HAIR RELATED CONDITIONS<br/>[FR] PROCÉDÉS DE TRAITEMENT DE TROUBLES LIÉS AU SYSTÈME PILEUX
    申请人:NOGRA PHARMA LTD
    公开号:WO2014041140A1
    公开(公告)日:2014-03-20
    Provided herein are methods for enhancing epidermal regeneration in a patient in need thereof, comprising topically administering to said patient a pharmaceutically acceptable composition comprising N-acetyl- 3-(4-aminophenyl)-2-methoxypropionic acid or a pharmaceutically acceptable salt or stereoisomer thereof, and a pharmaceutically acceptable excipient. For example, provided are methods for treating or ameliorating cicatricial alopecia, comprising topically administering to a patient in need thereof a pharmaceutically acceptable composition comprising the disclosed compounds. Also provided are methods for protecting hair follicle progenitor cells and compositions comprising same using the disclosed compounds.
    本文提供了一种增强患者表皮再生的方法,包括向该患者局部施用含有N-乙酰基-3-(4-氨基苯基)-2-甲氧基丙酸或其药学上可接受的盐或立体异构体和药学上可接受的赋形剂的药学上可接受的组合物。例如,本文提供了治疗或改善瘢痕性脱发的方法,包括向需要该药物的患者局部施用含有上述化合物的药学上可接受的组合物。此外,本文还提供了使用上述化合物保护毛囊祖细胞和含有这些化合物的组合物的方法。
  • [EN] METHODS OF INHIBITING HAIR GROWTH<br/>[FR] PROCÉDÉS D'INHIBITION DE LA CROISSANCE PILEUSE
    申请人:NOGRA PHARMA LTD
    公开号:WO2014041141A1
    公开(公告)日:2014-03-20
    Provided herein are methods for reducing mammalian hair growth using the disclosed compounds. Also provided herein are methods of inhibiting hair growth after hair removal of an area of mammalian skin of a mammal using the disclosed compounds.
    本文提供了使用披露的化合物减少哺乳动物毛发生长的方法。本文还提供了使用披露的化合物抑制哺乳动物皮肤区域脱毛后毛发生长的方法。
  • Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field
    申请人:Naccari Giancarlo
    公开号:US20130005813A1
    公开(公告)日:2013-01-03
    The present invention relates to compounds comprising the general formula (I), in which R 1 and R 2 , which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
    本发明涉及通式(I)的化合物,其中R1和R2可以相同或不同,选自包括-H或具有1到6个碳原子的线性或支链烷基或共同形成具有5或6个原子的芳香或脂肪环的群体;Y和Z可以相同或不同,选自包括-H、-OH、-COOH、-OR3、-CH(OR3)COOH的群体,其中R3选自H、苯基、苄基、-CF3或-CF2CF3、乙烯基、丙烯基和具有1到6个碳原子的线性或支链烷基。
  • METHODS OF TREATING HAIR RELATED CONDITIONS
    申请人:NOGRA PHARMA LIMITED
    公开号:US20150250749A1
    公开(公告)日:2015-09-10
    Provided herein are methods for enhancing epidermal regeneration in a patient in need thereof, comprising topically administering to said patient a pharmaceutically acceptable composition comprising N-acetyl-3-(4-aminophenyl)-2-methoxypropionic acid or a pharmaceutically acceptable salt or stereoisomer thereof, and a pharmaceutically acceptable excipient. For example, provided are methods for treating or ameliorating cicatricial alopecia, comprising topically administering to a patient in need thereof a pharmaceutically acceptable composition comprising the disclosed compounds. Also provided are methods for protecting hair follicle progenitor cells and compositions comprising same using the disclosed compounds.
    本文提供了一种增强病人表皮再生的方法,包括将一种药学上可接受的组合物局部施用于该病人,所述组合物包括N-乙酰基-3-(4-氨基苯基)-2-甲氧基丙酸或其药学上可接受的盐或立体异构体,以及药学上可接受的赋形剂。例如,本文提供了治疗或改善瘢痕性脱发的方法,包括将所述化合物的药学上可接受的组合物局部施用于需要治疗的病人。同时,本文还提供了使用所述化合物保护毛囊祖细胞的方法和组合物。
查看更多